Your Starting Point
Start Here
If you’ve just learned you carry the APOE ε4 allele — or you’ve been living with that knowledge and searching for clarity — this is where to begin.
“This is not a diagnosis. But it does change how you should think about your long-term brain health.“
The goal of this site is simple: to give you clear, physician-led guidance on what actually matters — and what doesn’t. Built by a practicing neurologist and APOE ε4 carrier who has navigated this landscape personally and professionally.
What APOE4 Actually Means
Most people receive this information without sufficient context. Here is what the peer-reviewed evidence actually shows.
APOE ε4 is a genetic variant of the apolipoprotein E (APOE) gene — the single most significant genetic risk factor for late-onset Alzheimer’s disease. Approximately 25% of the general population carries at least one copy. The ApoE4 protein isoform impairs amyloid-β clearance, promotes tau hyperphosphorylation, disrupts synaptic plasticity, and accelerates neuroinflammation — making it a central target of current Alzheimer’s research and prevention strategies.
APOE ε4 is not a diagnosis. It is not a guarantee of cognitive decline. Many APOE ε4 carriers live to advanced age with fully intact cognition. Risk is probabilistic — not deterministic. Understanding this distinction is the foundation of everything else on this site, and the reason that informed, proactive action is both rational and meaningful.
The information landscape oscillates between catastrophizing and false reassurance. Neither extreme serves you. Understanding which variables actually move risk — cardiovascular health, sleep, metabolic function, cognitive reserve — and which represent noise, is the critical gap this platform is built to fill.
What To Do Next
Three priorities every APOE ε4 carrier should address — in this order.
Start With the Fundamentals
Before optimizing protocols or pursuing emerging therapies, establish your baseline. Understand your genotype fully — heterozygous (one copy) versus homozygous (two copies) carries meaningfully different risk profiles and warrants different clinical conversations with your physician. Know what you’re working with before you act.
Learn What Actually Moves Risk
Blood pressure, cholesterol, physical activity, diabetes, hearing, and smoking are among the 14 modifiable risk factors the 2024 Lancet Commission linked to roughly 45% of dementia cases at the population level. In the US POINTER randomized trial, a structured lifestyle program improved cognition equally in ε4 carriers and non-carriers — carriers benefit fully from what works, but no trial supports a separate ε4-specific protocol. That evidence, not marketing, sets the content priorities on this site.
Avoid Common Mistakes
False reassurance from a single normal cognitive screen. Money spent on supplements without a meaningful evidence base. Avoiding a conversation with your physician out of fear. Each of these delays action during the years before symptoms — when risk factors such as blood pressure, cholesterol, and hearing loss can still be addressed, and when decisions about testing or trial participation can be made without urgency.
This platform is built and maintained by a practicing neurologist and pain medicine specialist with advanced training in public health — and a deeply personal stake in this mission. As a double board-certified neurologist, former US Naval Flight Surgeon, and APOE ε4 carrier with a strong family history of dementia, this work bridges the gap between what the peer-reviewed literature shows and what patients and families actually need to hear.
Every piece of content is grounded in peer-reviewed evidence from leading journals including JAMA Neurology, Nature Medicine, Alzheimer’s & Dementia, and Nature Reviews Neurology. Where evidence is preliminary or contested, it is presented as such — with the epistemic humility that rigorous science demands.
Former US Naval Flight Surgeon · Indianapolis, Indiana
Want a Clear Plan?
Four member resources address the questions carriers ask most — laboratory interpretation, which interventions the randomized evidence actually supports, how to run the conversation with your own physician, and how to evaluate a clinical trial. Each is available inside APOE4 Insights Premium.
Knowledge Is the First Step
Toward Action
Whether you are a carrier who just received your results, a family member watching a loved one decline, or a clinician seeking better tools — this platform is built for you. Start with the fundamentals, then go deeper.
This website is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Content is intended to supplement, not replace, the physician-patient relationship. Always consult a qualified healthcare provider regarding any medical condition or treatment decision.